Blueshift Asset Management, LLC Immunovant, Inc. Transaction History

Blueshift Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.33 - $9.32 $98,170 - $124,822	-13,393 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.01 - $11.37 $93,884 - $152,278	13,393 New	13,393 $116,000
Q1 2021 May 06, 2021	SELL	$13.08 - $49.6 $69,271 - $262,681	-5,296 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$36.36 - $52.71 $192,562 - $279,152	5,296 New	5,296 $245,000

211

66.9M

2.3M

631K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.